医药代表的现状.docVIP

超过一半的医生拒见医药代表 妮可.格雷 2015年9月4号 摘要: 1、According to an AccessMonitor report from ZS Associates, 53% of physicians practices implemented tight restrictions on pharmaceutical sales representatives reps.根据ZS咨询机构的访问监控报告，有53%的内科医生严格限制医药代表的到访。 2、Three years ago, only 35% of U.S. physicians practices had no access or limited access rules.Industry-wide consolidation amongh health providers is making it difficult for reps to gain access to physicians. 3年前，只有35%的内科医生实行限制访问规则。健康供应商的全工业合作使得医药代表们难以获得拜访内科医生的机会。 Dive Insight: 见解1、For years, reps have been bemoaning the increasing level of restrictions and ant